Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer

PURPOSES: The purposes of this study were to investigate the incidence of lymphedema in patients with breast cancer during and after adjuvant treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC), to identify predictors for development of lymphedema, and to describe consequences in daily...

Descripción completa

Detalles Bibliográficos
Autores principales: Hidding, Janine T., Beurskens, Carien H. G., van der Wees, Philip J., Bos, Wilmy C. A. M., Nijhuis-van der Sanden, Maria W. G., van Laarhoven, Hanneke W. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876252/
https://www.ncbi.nlm.nih.gov/pubmed/29127528
http://dx.doi.org/10.1007/s00520-017-3907-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5876252/
https://www.ncbi.nlm.nih.gov/pubmed/29127528
http://dx.doi.org/10.1007/s00520-017-3907-1

Ejemplares similares